Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Unresectable Pancreatic Carcinoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3907 Neoplasms 2703 Prostatic Neoplasms 1715 Colorectal Neoplasms 1551 Lung Neoplasms 1377 Carcinoma, Non-Small-Cell Lung 1117 Pancreatic Neoplasms 878 Multiple Myeloma 849 Leukemia, Myeloid, Acute 837 Lymphoma 825 Head and Neck Neoplasms 793 Leukemia 762 Precursor Cell Lymphoblastic Leukemia-Lymphoma 725 Neoplasm Metastasis 693 Colonic Neoplasms 693 Ovarian Neoplasms 683 Carcinoma, Hepatocellular 673 Melanoma 672 Stomach Neoplasms 670 Brain Neoplasms 627 Rectal Neoplasms 624 Lymphoma, Non-Hodgkin 581 Leukemia, Lymphocytic, Chronic, B-Cell 543 Uterine Cervical Neoplasms 530 Glioblastoma 488 Lymphoma, Follicular 486 Hodgkin Disease 479 Esophageal Neoplasms 475 Recurrence 472 Myelodysplastic Syndromes 453

Interventions

tocilizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02767557 2023-09-22

PACTO

Herlev Hospital

Phase 2 Completed

Gastrointestinal

Unresectable Pancreatic Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡